Morgan Lewis team pulls together for InnoPharma deal

Pfizer will acquire InnoPharma for an upfront cash payment of $225 million

Amy Pocino Kelly, partner in Morgan Lewis’s Employee Benefits and Executive Compensation Practice

A team from Morgan Lewis that included partners Barbara Shander, Joanne Soslow, Judith Walkoff, Amy Kelly and Kathleen Sanzo advised privately held pharmaceutical development company InnoPharma Inc. on its acquisition by Pfizer Inc. Under the terms of the agreement, Pfizer will acquire InnoPharma for an upfront cash payment of $225 million, with up to $135 million of contingent milestone payments.

The closing of the transaction is subject to U.S. regulatory approval and is expected to occur during the third quarter, according to the firm.

Contributing Author

author image

Amy I. Stickel

Amy I. Stickel has extensive experience covering the legal, financial and pharmaceutical industries as a writer and editor. A past managing editor of Corporate Legal Times and...

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.